National Center for Advancing Translational Sciences; Notice of Closed Meetings, 80321-80322 [2023-25464]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 13, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–25376 Filed 11–16–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, November 17,
2023, 10:00 a.m. to 04:00 p.m., National
Institutes of Health, Neuroscience
Center, 6001 Executive Boulevard,
Rockville, MD 20852 which was
published in the Federal Register on
November 3, 2023, 88 FR 77102.
This notice is being amended to
change this one-day meeting from
November 17, 2023, to November 27,
2023. The meeting time remains the
same. The meeting is closed to the
public.
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
80321
Dated: November 13, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–25404 Filed 11–16–23; 8:45 am]
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Establishment of the Board of
Scientific Counselors, Division of
Translational Toxicology, National
Institute of Environmental Health
Sciences
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
1001–1014), the Director, National
Institutes of Health (NIH) announces the
establishment of the Board of Scientific
Counselors, Division of Translational
Toxicology, National Institute of
Environmental Health Sciences, as
authorized by 42 U.S.C. 282(b)(16),
section 402(b)(16) of the Public Health
Service Act, as amended.
The Director, NIH, has determined
that the Board of Scientific Counselors,
Division of Translational Toxicology,
National Institute of Environmental
Health Sciences is in the public interest
in connection with the performance of
duties imposed on NIH by law, and that
these duties can best be performed
through the advice and counsel of the
committee.
The committee will review and
evaluate the intramural program and the
work of tenured, tenure track, and staff
scientists and physicians and shall also,
as requested by the Director, NIH,
undertake peer review of extramural
funding applications as required by
section 492 of the Public Health Service
Act, as amended.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or Claire.Harris@nih.gov.
Dated: November 13, 2023.
Monica M. Bertagnolli,
Director, National Institutes of Health.
[FR Doc. 2023–25472 Filed 11–16–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative and
Innovative Acceleration Awards.
Date: February 7, 2024.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1068, Bethesda, MD 20892, (301) 435–0810,
lourdes.ponce@nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Understudied Proteins
Associated with Rare Diseases (R03) Review.
Date: February 29, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D.
Scientific Review Officer Scientific Review
Branch Division of Extramural Activities
National Center for Advancing Translational
Sciences 6701 Democracy Boulevard, MSC
4874 Bethesda, MD 20892 (301) 827–4312
ming.yan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
E:\FR\FM\17NON1.SGM
17NON1
80322
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
Dated: November 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–25464 Filed 11–16–23; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurodegenerative Disorders and Aging.
Date: December 6, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, (301) 827–4446,
bellingerjd@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–25465 Filed 11–16–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel Clinical
Trials Planning Program.
Date: January 23, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W106, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Eduardo Emilio Chufan,
Ph.D. Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, Maryland
20850 240–276–7975, chufanee@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Metastasis
Research Network (U01).
Date: February 1, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W606, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Bruce Daniel Hissong,
Ph.D. Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W606 Rockville, Maryland 20850,
240–276–7752, bruce.hissong@nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel, Diet, Lipid
Metabolism, and Tumor Growth and
Progression.
Date: February 1, 2024.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850 (Virtual
Meeting).
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville,
Maryland 20850, 240–672–6175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis, Panel SEP–4:
NCI Clinical and Translational Cancer
Research.
Date: February 6–7, 2024.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, (Virtual
Meeting).
Contact Person: Ombretta Salvucci,
Ph.D.,Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W264,
Rockville, Maryland 20850, 240–276–7286,
salvucco@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis, Panel SEP–1: NCI
Clinical and Translational Cancer Research.
Date: February 7, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, Maryland 20850, (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI SPORE
(P50) Review SEP–I.
Date: February 15–16, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W244, Rockville, Maryland 20850, (Virtual
Meeting).
Contact Person: John Paul Cairns, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Rockville, Maryland 20850, 301–461–0303,
paul.cairns@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Outstanding Investigator Award (R35).
Date: February 15–16, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, Maryland 20850, (Virtual
Meeting).
Contact Person: David G. Ransom, Ph.D.,
Chief, Scientific Review Officer, Special
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Pages 80321-80322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25464]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; CTSA Collaborative and Innovative
Acceleration Awards.
Date: February 7, 2024.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1068, Bethesda, MD 20892, (301) 435-0810,
[email protected].
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Understudied Proteins Associated
with Rare Diseases (R03) Review.
Date: February 29, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D. Scientific Review Officer
Scientific Review Branch Division of Extramural Activities National
Center for Advancing Translational Sciences 6701 Democracy
Boulevard, MSC 4874 Bethesda, MD 20892 (301) 827-4312
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
[[Page 80322]]
Dated: November 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-25464 Filed 11-16-23; 8:45 am]
BILLING CODE 4140-01-P
